Page last updated: 2024-11-02

oxymetazoline and Keratoconjunctivitis

oxymetazoline has been researched along with Keratoconjunctivitis in 1 studies

Oxymetazoline: A direct acting sympathomimetic used as a vasoconstrictor to relieve nasal congestion. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1251)
oxymetazoline : A member of the class of phenols that is 2,4-dimethylphenol which is substituted at positions 3 and 6 by 4,5-dihydro-1H-imidazol-2-ylmethyl and tert-butyl groups, respectively. A direct-acting sympathomimetic with marked alpha-adrenergic activity, it is a vasoconstrictor that is used (generally as the hydrochloride salt) to relieve nasal congestion.

Keratoconjunctivitis: Simultaneous inflammation of the cornea and conjunctiva.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hutter, H1

Trials

1 trial available for oxymetazoline and Keratoconjunctivitis

ArticleYear
[Epidemic keratoconjunctivitis: treatment results during an epidemic].
    Klinische Monatsblatter fur Augenheilkunde, 1990, Volume: 197, Issue:3

    Topics: Acrylic Resins; Adenovirus Infections, Human; Adolescent; Adult; Aged; Aged, 80 and over; Child; Chi

1990